48
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis

, , , , , , , , , & show all
Pages 245-255 | Published online: 11 Jan 2013

References

  • BergersGBenjaminLETumorigenesis and the angiogenic switchNat Rev Cancer20033640141012778130
  • HoodJDChereshDARole of integrins in cell invasion and migrationNat Rev Cancer2002229110012635172
  • Morales-AvilaEFerro-FloresGOcampo-GarcíaBEMultimeric system of 99 mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor alpha(v)beta(3) expressionBioconjug Chem201122591392221513349
  • XieHDiagaradjanePDeorukhkarAAIntegrin alphavbeta3-targeted gold nanoshells augment tumor vasculature-specific imaging and therapyInt J Nanomedicine2011625926921423588
  • LanzardoSContiLBrioschiCA new optical imaging probe targeting alphaVbeta3 integrin in glioblastoma xenograftsContrast Media Mol Imaging20116644945822144022
  • StreeterJEGessnerRCTsurutaJFeingoldSDaytonPAAssessment of molecular imaging of angiogenesis with three-dimensional ultrasonographyMol Imaging201110646046822201537
  • BulteJWKraitchmanDLIron oxide MR contrast agents for molecular and cellular imagingNMR Biomed200417748449915526347
  • Wahajuddin AroraSSuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInt J Nanomedicine201273445347122848170
  • YuMKJeongYYParkJDrug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivoAngew Chem Int Ed Engl200847295362536518551493
  • GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
  • TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
  • MulderWJStrijkersGJvan TilborgGAGriffioenAWNicolayKLipid-based nanoparticles for contrast-enhanced MRI and molecular imagingNMR Biomed200619114216416450332
  • PaganelliGMagnaniPZitoFPre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99 mTc]PnAO-biotinEur J Nucl Med19942143143218005155
  • PaganelliGMagnaniPZitoFThree-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patientsCancer Res19915121596059661933860
  • DiamandisEPChristopoulosTKThe biotin-(strept)avidin system: principles and applications in biotechnologyClin Chem19913756256362032315
  • De CuyperMJoniauMMagnetoliposomes. Formation and structural characterizationEur Biophys J19881553113193366097
  • BolesKSSchmiederAHKochAWMR angiogenesis imaging with Robo4- vs alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma modelFASEB J201024114262427020585027
  • van TilborgGAMulderWJvan der SchaftDWImproved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomesNeoplasia200810121459146919048124
  • LiWSuBMengSRGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studiesEur J Radiol201180259860621316892
  • BulteJWde CuyperMDespresDFrankJAShort- vs long-circulating magnetoliposomes as bone marrow-seeking MR contrast agentsJ Magn Reson Imaging19999232933510077033
  • EfremovaNVBondurantBO’BrienDFLeckbandDEMeasurements of interbilayer forces and protein adsorption on uncharged lipid bilayers displaying poly(ethylene glycol) chainsBiochemistry200039123441345110727239
  • DingNLuYLeeRJFolate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imagingInt J Nanomedicine201162513252022072885
  • SipkinsDAChereshDAKazemiMRNevinLMBednarskiMDLiKCDetection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imagingNat Med1998456236269585240
  • HsiehWJLiangCJChiehJJIn vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticlesInt J Nanomedicine201272833284222745546
  • QiaoJLiSWeiLHER2 targeted molecular MR imaging using a de novo designed protein contrast agentPLoS One201163e1810321455310
  • SchmiederAHCaruthersSDZhangHThree-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse modelFASEB J200822124179418918697838
  • EspositoGGeninatti CrichSAimeSEfficient cellular labeling by CD44 receptor-mediated uptake of cationic liposomes functionalized with hyaluronic acid and loaded with MRI contrast agentsChem Med Chem20083121858186218988207
  • SharkeyRMKaracayHCardilloTMImproving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methodsClin Cancer Res20051119 Pt 27109s7121s16203810
  • GoodwinDAMearesCFPretargeting: general principles; October 10–12, 1996Cancer199780Suppl 12267526809406724
  • ZhuWOkollieBBhujwallaZMArtemovDPAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approachMagn Reson Med200859467968518302223
  • FrascioneDDiwokyCAlmerGUltrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probesInt J Nanomedicine201272349235922661890
  • ChenWJarzynaPAvan TilborgGARGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probeFASEB J20102461689169920075195
  • MulderWJStrijkersGJHabetsJWMR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticleFASEB J200519142008201016204353
  • KluzaEJacobsIHectorsSJDual-targeting of alphavbeta3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivoJ Control Release2012158220721422079810